Indian Navy Purified Rabies Vaccine & Anti-D (Rho) Immunoglobulin Tender 2026 - GEM/2026/B/7673972

Bid submission requires PAN, GSTIN, cancelled cheque, and EFT mandate; vendors must create a vendor code on the GEM portal. Ensure compliant packaging, potency ≥ 2.5 IU for rabies vaccine, and confirm delivery terms under the 50% variation option. Include all mandated documents and bank details to participate.

Submit PAN card, GSTIN, cancelled cheque, and EFT mandate validated by bank; ensure vendor code creation is completed. Additional documents may be requested on the portal, including company details and relevant certifications. Prepare these before the bid deadline to avoid disqualification.

The vaccine must have potency not less than 2.5 IU per ampoule/vial/PFS; no explicit brand or ISI/ISO references are listed. The anti-D immunoglobulin component is a monoclonal human lyophilised freeze-dried vial at 300/350 mcg. No additional packaging or stability data provided in the data.

The purchaser may increase or decrease the order by up to 50% of the bid quantity at contract placement and during the contract currency at the contracted rates. Delivery timing adjusts based on the calculated extended period, with a minimum 30 days.

Delivery period starts from the last date of the original delivery order. If the option clause is exercised, additional time is calculated as (Increased quantity ÷ Original quantity) × Original delivery period, with a minimum of 30 days.

Provide PAN, GSTIN, cancelled cheque, and EFT mandate certified by a bank. This ensures eligibility to participate on the GEM portal for Indian Navy procurement and vaccine-related tender opportunities.

No BOQ items or estimated value are disclosed in the tender data. Bidders should rely on the option clause and standard procurement terms while preparing quotations and ensure compliance with vendor documentation.

The tender data does not specify ISI/ISO standards or brand requirements. Bidders should verify post-bid on the GEM portal; ensure potency specifications and regulatory compliance for vaccine-grade products as applicable to government procurement.